Burden and trends of chronic kidney disease due to type 2 diabetes mellitus in China and G20 countries, 1990–2023: a comparative analysis - Report - MDSpire

Burden and trends of chronic kidney disease due to type 2 diabetes mellitus in China and G20 countries, 1990–2023: a comparative analysis

  • By

  • Jincheng Li

  • Xinyu Li

  • Hongtao Zhao

  • Xinyu Yang

  • Yulin Li

  • June 10, 2026

  • 0 min

Share

Comparative Analysis of T2DM-CKD Burden in China and G20 Nations

Overview

{'projected_increase': 'Specify the baseline year for the 23.2% increase in incidence rates.'}

Background

{'statistics': 'Include specific CKD prevalence statistics for China.'}

Data Highlights

{'table': 'Add definitions for AAPC and SDI.'}

Key Findings

{'finding': 'Discuss implications of rising absolute burden.'}

Clinical Implications

{'strategies': 'Suggest specific early detection and management practices.'}

Conclusion

{'collaboration': 'Emphasize the need for international collaboration.'}

Related Resources & Content

  1. Institute for Health Metrics and Evaluation, GBD 2023 -- Global Burden of Disease Study 2023
  2. American Diabetes Association, 2026 -- Section 11: Chronic Kidney Disease and Risk Management
  3. Global Burden of Disease Study 2023, ScienceDirect -- Global, regional, and national burden of chronic kidney disease
  4. npj Digital Medicine — Risk Prediction of Chronic Kidney Disease Progression in Type 2 Diabetes Mellitus Across Diverse Populations
  5. The Impact of Elevated Body Mass Index on Colorectal Cancer in China: Analysis from 1990 to 2021 and Projections for 2035
  6. Frontiers in Medicine — Long-term trends in the burden of leukemia subtypes in China from 1990 to 2021: a Joinpoint regression and age-period-cohort analysis based on GBD 2021
  7. Clinical Rheumatology — Assessment of Osteoarthritis Prevalence in China from 1990 to 2019: Insights from the 2019 Global Burden of Disease Study
  8. Global Burden of Disease Study 2023 Analysis
  9. ADA Standards of Care in Diabetes 2026
  10. Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease - American College of Cardiology

Original Source(s)

Burden and trends of chronic kidney disease due to type 2 diabetes mellitus in China and G20 countries, 1990–2023: a comparative analysis

  • by Jincheng Li, Xinyu Li, Hongtao Zhao, Xinyu Yang, Yulin Li

  • June 10, 2026

Related Content

Correction to: “Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors”

  • February 9, 2026

Lifetime prevention must start before conception

Utilizing Machine Learning to Identify Risk Factors for Diabetic Microvascular Complications and Develop a Predictive Model with Gradient Boosting Decision Trees